Status
Conditions
Treatments
About
It aims to find the effectiveness and the safety of Virtual Reality (Caterna, DOBOSO, item code: SJ-VRS2018) to facilitate amblyopia treatment combining spectacles and occlusion. And it also aims to test whether amblyopia treatment outcomes with spectacles, occlusion and VR are significant better than those without VR, but with spectacles and occlusion.
The experiment arm is designed to use the Caterna VR to treat amblyopia for total consistent 13 weeks, 3 times per week, while the control arm is not.
Both arms are best optical correction and with patch the non-amblyopia eye 2 hours or 6 hours per day.
All eyes are followed up for total 13 weeks.
Full description
The amblyopia eye will see the video content from Caterna VR a little bit earlier (12 ms) than the other non-amblyopia eye.
Also, the illumination and contrast are both adjusted to balance 2 eyes' clarity.
One VR treatment sequence is 30 minutes with 5 minutes break in the middle.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
300 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Taylor Zhu, MS; Jenny Qiu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal